Home > Category > Chiral Reagent > 1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide

1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide

Daicel≥98%,99%e.e

Catalog No：200228-50MG CAS No.：NA MDLNo： Brand:Daicel purity：≥98%,99%e.e 特性： Purpose:

Share

Size	Availability	Price(USD)
50MG	请咨询	$2205.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide
CAS	NA
Formula	C₄₈H₅₉F₃NO₇PS

Related literature

Sorry, there is no relevant literature

Related

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

History

1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide

1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide

NA ≥98%,99%e.e

1,1,1-Trifluoro-N-[(11bR)-4-oxido-2,6-di-9-phenanthrenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide

1,1,1-Trifluoro-N-[(11bR)-4-oxido-2,6-di-9-phenanthrenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide

937028-51-8 ≥98%,99%e.e.

1,1,1-Trifluoro-N-[(11bS)-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide

1,1,1-Trifluoro-N-[(11bS)-4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide

908338-42-1 ≥98%,-

1,1,1-Trifluoro-N-[(11aS)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide

1,1,1-Trifluoro-N-[(11aS)-10,11,12,13-tetrahydro-5-oxido-3,7-bis[3,5-bis(tert-butyl)-4-methoxyphenyl]diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide

NA ≥98%,99%e.e

[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-phenyloxazole-κN3]-(+)-Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

1194050-21-9 ≥98%,99%e.e.

[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-(+)Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

[(1,2,5,6-η)-1,5-Cyclooctadiene][(4S)-2-[(5S)-6-(diphenylphosphino-κP)spiro[4.4]nona-1,6-dien-1-yl]-4,5-dihydro-4-(phenylmethyl)oxazole-κN3]-(+)Iridium(I) Tetrakis[3,5-bis(trifluoromethyl)phenyl]borate

1194050-19-5 ≥98%,-

(R)-2'-(Diphenylphosphinyl)-[1,1'-binaphthalen]-2-ol

(R)-2'-(Diphenylphosphinyl)-[1,1'-binaphthalen]-2-ol

132548-91-5 ≥98%,99%e.e.

1,1'-(1S)-[1,1'-Binaphthalene]-2,2'-diylbis[bis(4-methylphenyl)phosphine]

1,1'-(1S)-[1,1'-Binaphthalene]-2,2'-diylbis[bis(4-methylphenyl)phosphine]

100165-88-6 ≥98%,-

1,1'-[[(4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl]bis(methylene)]bis[1,1-diphenyl-phosphine oxide]

1,1'-[[(4S,5S)-2,2-Dimethyl-1,3-dioxolane-4,5-diyl]bis(methylene)]bis[1,1-diphenyl-phosphine oxide]

187989-59-9 ≥98%,99%e.e.